middle.news
How ReNerve’s Deep Dermal Product Could Transform US Surgical Markets
9:47am on Monday 18th of August, 2025 AEST
•
Healthcare
Read Story
How ReNerve’s Deep Dermal Product Could Transform US Surgical Markets
9:47am on Monday 18th of August, 2025 AEST
Key Points
First sale and clinical use of deep dermal tissue product in the US
Expansion beyond nerve repair into dermal and amniotic tissue markets
Strategic partnership with Berkeley Biologics driving commercialization
53% revenue growth in FY25 with $271k sales
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE